Direct Atipamezole Hydrochloride Crystallization from Aqueous Acid

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

The existing methods for preparing atipamezole hydrochloride require isolating the atipamezole base before converting it to its hydrochloride salt, which is inefficient and involves the use of solvents like methylene chloride and ethyl acetate.

Innovation Solution

A method that directly isolates crystalline atipamezole hydrochloride from an aqueous solution through hydrogenation in hydrochloric acid, concentrating, cooling, and crystallizing, without the need for intermediate base isolation and using alternative solvents.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If the conventional method of isolating atipamezole base before converting to hydrochloride salt is used, then the product can be obtained, but the process is inefficient and requires multiple solvents (methylene chloride and ethyl acetate)

Engineering Contradiction:
Improveprocess efficiencyVSAvoidnumber of solvents and isolation steps
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The patent merges the hydrogenation step and the salt formation step into a single integrated process. The atipamezole base is hydrogenated directly in the presence of hydrochloric acid, so that the free base is immediately converted to its hydrochloride salt during the reaction, eliminating the need for separate isolation and conversion steps

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The patent removes the intermediate isolation of atipamezole base from the process entirely. By conducting hydrogenation in aqueous hydrochloric acid solution, the base is never isolated - it is directly converted to the hydrochloride salt form, taking out the unnecessary intermediate step and associated solvents

Inventive Principle:
Principle #2Taking out (Extraction)

2Ease of manufacture

If methylene chloride and ethyl acetate solvents are used for isolation and conversion, then atipamezole hydrochloride can be obtained, but the process becomes less economical and more complex

Engineering Contradiction:
Improveprocess simplicityVSAvoidsolvent consumption
Core Design Contradiction:
Ease of manufactureVSQuantity of substance

Solution Approach 1:

The patent changes the solvent system from organic solvents (methylene chloride, ethyl acetate) to an aqueous hydrochloric acid solution. This parameter change in the solvent medium allows the reaction and crystallization to proceed directly in water, eliminating the need for organic solvent extraction and conversion steps

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent uses hydrochloric acid as an intermediary that serves multiple functions: it provides the acidic environment for hydrogenation, supplies the chloride ions for salt formation, and acts as the solvent medium throughout the process, eliminating the need for separate solvent systems

Inventive Principle:
Principle #24Intermediary (Mediator)

3Loss of time

If intermediate base isolation is performed, then conversion to hydrochloride salt is possible, but processing time increases and yield is reduced

Engineering Contradiction:
Improveprocessing timeVSAvoidoverall yield
Core Design Contradiction:
Loss of timeVSProductivity

Solution Approach 1:

The patent establishes continuous useful action by maintaining the atipamezole in solution throughout the entire process. The hydrogenation, salt formation, and crystallization occur in sequence without isolating the intermediate base, keeping the material continuously in a usable form and minimizing processing time and losses

Inventive Principle:
Principle #20Continuity of useful action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method is more efficient and economical, eliminating the need for solvent use and directly producing crystalline atipamezole hydrochloride, with improved yield and reduced processing time.

Implementation Method 1

hydrogenation of compound of formula (II) or a salt thereof in aqueous solution of hydrochloric acid under catalyst

Methodology Applied
Scientific EffectHydrogenation: Hydrogenation

Implementation Method 2

hydrogenation of compound of formula (II) or a salt thereof in aqueous solution of hydrochloric acid under catalyst

Methodology Applied
Scientific EffectCatalysis: Catalysis

Implementation Method 3

cooling the concentrated solution; and recovering crystallized atipamezole hydrochloride

Methodology Applied
Scientific EffectCrystallization: Crystallisation

Data Source

PatentUS7642279B2Atipamezole hydrochloride crystallization method
Publication Date: 2010.01.05 ORION CORP(FI)
  • US7642279B2 patent drawing
  • US7642279B2 patent drawing
  • US7642279B2 patent drawing

AI summary

A method of isolating atipamezole hydrocloride as a crystalline salt is provided.